Pregabalin Capsule
Product Images NDC 71335-1740

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Pregabalin (NDC 71335-1740). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl713351740)

This appears to be a label of a medicine package. It mentions the name of the medicine "Lyrica 100mg", the form of the medicine "capsule", the manufacturer "Alkem Laboratories Limited" and the expiration date. It also provides packaging information such as the NDC number and the person who packaged it. It includes the address to store the medicine and advises to keep the medicine out of reach of children.*

FDA Label Image

Pregabalin-equation (Pregabalin Equation)

This text seems to be a formula for estimating the creatinine clearance (CLCr) for female patients based on their age, weight, and serum creatinine level. However, the formula itself is incomplete and cannot be properly evaluated without additional information.*

FDA Label Image

Pregabalin-figure-6 (Pregabalin Figure 6)

This appears to be a table displaying data from two studies, denoted as "Study E1" and "Study E3". The table shows percentages for various treatments, dosages, and placebo. There seem to be some statistically significant results when compared to the placebo, but the details are unclear without further context.*

FDA Label Image

Pregabalin-figure-7 (Pregabalin Figure 7)

FDA Label Image

Study Dpn 1 (Pregabalin Image 1)

FDA Label Image

Study Sci 1 (Pregabalin Image 10)

FDA Label Image

Pain Intensity-study Sci 2 (Pregabalin Image 11)

FDA Label Image

Study Dpn 2 (Pregabalin Image 2)

FDA Label Image

Study Phn 1 (Pregabalin Image 3)

FDA Label Image

Study Phn 2 (Pregabalin Image 4)

Percentage Improvement in Pain from Baseline is available. The rest of the text is not readable and appears to be a combination of letters and numbers without a clear context.*

FDA Label Image

Study Phn 3 (Pregabalin Image 5)

FDA Label Image

Fibromyalgia Study F1 (Pregabalin Image 8)

FDA Label Image

Fibromyalgia Study F2 (Pregabalin Image 9)

FDA Label Image

Pregabalin Structure (Pregabalin Srtuc 1)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.